HBSP (USA)
-
Radically Simple IT (Spanish version)
Upton, David M.; Staats, Bradley R.Article HBS-R0803JInformation Technologiesthe difficulty and expense of mapping out all requirements before a project starts because people often cannot specify everything that they need beforehand; the other unanticipated needs that almost always arise once a system is in operation; and the tricky task of persuading people to use and "own" it. Japan's Shinsei Bank emerged during the authors' research as a standout among the companies applying the path-based method. The firm designed, b...Starting at €8.20
-
Merck: La administración de Vioxx (D)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-111S05Knowledge and CommunicationStarting at €5.74
-
Lean Knowledge Work
Staats, Bradley R.; Upton, David M.Article HBS-R1110G-EService and Operations ManagementMany manufacturing companies and some service firms have reaped considerable benefits by applying variations of the Toyota Production System, a method for making operations "lean" through relentless efforts to increase quality and efficiency and eliminate waste. But conventional wisdom holds that lean principles don't lend themselves to knowledge work, which involves judgment and expertise, not the sorts of repetitive, easily specified tasks foun...Starting at €8.20
-
Merck: Managing Vioxx (A)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-109080-EKnowledge and CommunicationThis two-class case series allows students to stand in the shoes of CEO Ray Gilmartin during the unfolding stages of a reputational crisis. Merck's mission statement claims to "put patients first," but the company is widely criticized for putting profit bStarting at €8.20
-
Pfizer: Letter from the Chairman (B)
Simons, Robert L.; Rosenberg, KathrynCase HBS-110004-EAccounting and ControlThis case continues the story begun in "Pfizer: A Letter From The Chairman" (HBS No. 9-110-003), revealing the letter Chairman and CEO Jeff Kindler wrote for the 2008 Annual Report.Starting at €5.74
-
Pfizer: Letter from the Chairman (A) and (B), Teaching Note
Simons, Robert L.; Rosenberg, KathrynTeaching Note HBS-110067-EAccounting and ControlTeaching Note for 110003 and 110004.Starting at €0.00
-
Sydney IVF: Stem Cell Research, Teaching Note
Simons, Robert L.; Rosenberg, KathrynTeaching Note HBS-110092-EStrategyTeaching Note for 109017.Starting at €0.00
-
TCS: The MCA 21 Project
Upton, David M.; Staats, Bradley R.Case HBS-609024-ETata Consultancy Services (TCS), a leading outsourced software services provider based in India, must decide whether to bid on a high-profile government project within India. The project, if completed successfully, would mark another step in TCS' progression from a provider of low-cost technical resources to their goal of becoming an end-to-end technology enabled services provider. However, the project was not only complex but also presented cons...Starting at €8.20
-
Gerson Lehrman Group: Managing Risks
Groysberg, Boris; Healy, Paul M.; Abbott, Sarah L.Case HBS-412004-EIt was June 2011 and Alexander Saint-Amand, President and CEO of Gerson Lehrman Group, the largest expert network firm globally, has found his firm once again in the midst of controversy. This controversy centered around a number of insider trading cases that had been brought against consultants working for competing expert network firms. While GLG was in no way implicated in these cases, and GLG had invested significantly in its compliance polic...Starting at €8.20
-
Constellation Brands' Investment in Canopy Growth: Aiming High
Gilson, Stuart C.; Abbott, Sarah L.Case HBS-220044-EFinanceIn 2017, Constellation Brands, the U.S. based beverage company, acquired a 9.9% equity interest in the Canadian marijuana company, Canopy Growth. In 2018, Constellation announced a subsequent investment in Canopy-taking its ownership interest to 37%. However, Canopy's performance had been volatile and net losses had increased since the investment. In an effort to get into the cannabis market early, had Constellation Brands been too early?Starting at €8.20